Cardiff Oncology, Inc. (CRDF) — DEF 14A Filings
All DEF 14A filings from Cardiff Oncology, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Cardiff Oncology DEF 14A: Executive Compensation Details
— Apr 29, 2025 Risk: medium
Cardiff Oncology, Inc. filed a DEF 14A on April 29, 2025, detailing executive compensation for the fiscal years ending December 31, 2022, 2023, and 2024. The fi -
Cardiff Oncology, Inc. Files Definitive Proxy Statement
— Apr 25, 2024 Risk: low
Cardiff Oncology, Inc. (CRDF) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. Cardiff Oncology, Inc. filed a Definitive Proxy Statement (DEF 1
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX